# KPI infrastructure failures are destroying PE rollup value

**Private equity firms face a systemic crisis: the operational value creation strategies they now depend on for returns are built on unreliable KPI infrastructure that silently erodes billions in portfolio value.** With entry multiples at **11.8× EBITDA** and holding periods stretching to **seven years**, PE firms can no longer rely on multiple expansion or financial engineering — operational improvement must generate returns. Yet **72% of PE firms identify weak data and KPI reporting as the single biggest finance issue at exit**, and **72% of firms realize less than 75% of planned value** from their value creation plans. The root cause is not strategic — it is infrastructural. Across healthcare rollups running five different EHR platforms and B2B SaaS portfolios with incompatible CRM and billing stacks, the inability to define, collect, harmonize, and sustain consistent KPIs across heterogeneous entities compounds with every bolt-on acquisition, turning what should be a data-driven value creation engine into what practitioners describe as a “Tower of Financial Babel.”

This report documents the specific failure modes, quantified impacts, and technology gaps across six phases of the KPI lifecycle in PE-backed rollups, with equal emphasis on healthcare platforms (physician practice management, behavioral health, home health, DSOs) and B2B SaaS / software-enabled services platforms.

---

## Phase 1: The KPI definition problem creates false comparability

### The core failure: “same metric, different meaning”

The most insidious problem in multi-entity rollups is not missing data — it is data that *appears* comparable but is not. **40% of SaaS companies miscalculate or inconsistently define ARR**, according to a Maxio survey of 50 companies. As FundCount’s 2026 analysis put it bluntly: **“If ‘EBITDA’ and ‘ARR’ aren’t consistently defined (and audited), dashboards become argument generators.”**

This problem manifests differently across verticals but follows the same pattern: acquired entities define metrics using local conventions shaped by their specific systems, payer mixes, customer bases, and accounting practices. When a PE firm attempts to roll these up into a consolidated view, the numbers are technically addable but semantically incompatible.

**In healthcare rollups**, the definition conflicts are particularly acute. A “visit” can mean three fundamentally different things depending on the practice: a scheduled appointment (including no-shows), a completed clinical encounter documented in the EHR, or a billable event with an associated CPT code. A practice reporting 100 weekly “visits” by the appointment definition may show only 78 by the charge-based definition — a **22% discrepancy in the same metric**. “Provider utilization” is similarly fragmented: some practices calculate it as booked appointments divided by available slots, others as patient care hours divided by total hours, still others as actual wRVUs versus specialty benchmarks. MGMA research found that even within a single 700-provider organization, “NPR/wRVU was not well defined” and leadership “struggled to determine if variances were based on payer mix, service mix or revenue cycle efficiency.” Net collection rates carry a benchmark of 95–96%, but the denominator varies between gross charges and allowed amounts across practices, making cross-entity comparison meaningless without normalization.

**In B2B SaaS rollups**, ARR — the single most important valuation metric — has no standardized definition. Ordway Labs’ analysis of public SaaS companies found variations across seven dimensions: terminology (Annual Recurring Revenue vs. Annualized Revenue Run Rate), formula (MRR × 12 vs. last month GAAP × 12 vs. TCV ÷ contract length), recognition timing (at booking vs. implementation vs. GAAP recognition), customer segments included, revenue streams included, channel treatment, and currency policy. Adobe uses constant-currency adjustments; BigCommerce includes one-time partner revenue; MongoDB uses a 90-day rolling average for consumption products. When a PE firm acquires five SaaS companies, producing a consolidated ARR figure requires mapping each methodology, reconciling against GAAP, and establishing a unified definition — a process that can consume weeks to months.

Churn is the most contested SaaS metric. SaaS Capital’s April 2025 analysis demonstrated how methodology choice alone — annual vs. monthly measurement, gross vs. net, compounding approach — can make gross retention appear anywhere from **35% to 100% for the same company**. ServiceTitan’s IPO filing reported 95% GRR, but SaaS Capital noted the calculation excluded downsells and only counted complete churns, a methodological choice that materially inflates the figure. For every 1% increase in revenue retention, a SaaS company’s value increases by **12% after five years**, making these definition differences worth millions in implied valuation.

### System heterogeneity as root cause

The KPI definition problem is not primarily a governance problem — it is a systems problem. Each acquired entity’s metrics are shaped by the specific data models, field definitions, and calculation logic of the software they run. A healthcare rollup with practices on Epic, Athenahealth, eClinicalWorks, Kareo, and ModMed has five fundamentally different data architectures defining how encounters are recorded, how charges are captured, and how payments are posted. A SaaS rollup with companies on Stripe/HubSpot/QuickBooks, Zuora/Salesforce/NetSuite, and Chargebee/Pipedrive/Xero has three incompatible billing-CRM-accounting stacks generating structurally different revenue data.

As one practitioner described: **“PE firms and their operators are usually trying to make management and value transformation decisions while sorting through a legion of information management systems with different charts of accounts, conflicting formats, and diverse accounting policies.”**

### Current approaches and their limitations

PE firms currently attempt four approaches to KPI harmonization, each with significant drawbacks:

- **Full system migration** (forcing all entities onto one ERP/EHR): Extremely costly ($150K–$500K per entity for ERP; $400K–$800K for a 50-provider EHR migration), takes 12–18+ months, and causes operational disruption. Aveanna Healthcare’s consolidation of four clinical systems to a single platform caused a “difficult quarter” with admissions falling 2.6% and unexpected revenue reserve adjustments. One PE practitioner warned these migrations are “very risky and prone to failure, often running late and way over budget.”
- **Manual spreadsheet consolidation**: Still used by the majority — **54% of portfolio companies use email with attachments** for PE data collection. Error-prone, non-reproducible, and collapses at scale.
- **Standardized KPI collection platforms** (Chronograph, iLevel, Cobalt): These tools collect data *from* portfolio companies but do not integrate *with* their source systems. They harmonize what companies report, not what systems contain, leaving the definition problem unsolved.
- **Custom data warehouse approaches**: Emerging best practice using Snowflake/dbt/BI tools, but requires dedicated data engineering teams (2–5 FTEs) and still demands manual semantic mapping for each entity. The transformation logic must be hand-coded by analysts who understand both the source system and the target KPI definition.

---

## Phase 2: Data collection and integration break under rollup complexity

### Timeline to first consolidated report

The gap between acquisition close and first reliable consolidated KPI report is a critical value-creation dead zone. Practitioner estimates and industry research suggest:

| Scenario | Timeline | Conditions |
| --- | --- | --- |
| Best case | 4–8 weeks | Single add-on, compatible systems, pre-built integration playbook |
| Median | 3–6 months | Multi-entity rollup, heterogeneous systems, meaningful operating dashboard |
| Worst case | 12–18+ months | 10+ entities, different EHR/ERP platforms, full operational harmonization |

Spaulding Ridge notes that onboarding portfolio company data “is a full-time job for several people” and warns it “could be weeks or even months before your company has access to comprehensive performance data from a new acquisition.” For healthcare rollups, revenue cycle analytics implementation alone takes 6–12 months, with cloud-based solutions delivering initial insights within 60–90 days at best.

### Cost structure of consolidated reporting

Building and maintaining consolidated KPI infrastructure across a 5–15 entity rollup requires significant ongoing investment. A dedicated data integration team of **2–5 FTEs at burdened rates of $150K–$250K** represents **$300K–$1.25M annually** in people costs alone, before software licensing and consulting. SR Analytics documents that mid-market PE firms ($1B–$3B AUM) spend **$250K–$400K in Year 1** for cloud-based data platforms with **$150K–$250K in annual ongoing costs**. The average mid-market fund wastes **$2–5M annually** on missed operational improvements and delayed exits due to poor portfolio visibility.

For healthcare specifically, per-practice EHR implementation costs $162,000 on average with $85,500 for first-year maintenance. Data migration alone costs **$50K–$250K per system**, with interoperability integration adding **$20K–$150K per connection**. PE-backed healthcare organizations should plan for **200–300% data volume increases** within a typical hold period.

### Compounding complexity with each acquisition

The integration burden is nonlinear. Each additional entity does not simply add one more data source — it creates N-1 additional reconciliation relationships with every existing entity and introduces new system variants, data formats, and definition conflicts. Pemeco Consulting captures this dynamic precisely: **“As bolt-on volume increases, inconsistency in processes, data, and controls becomes one of the fastest destroyers of value.”** Proactive Technology Management describes how early point-to-point integration fixes create “integration spaghetti” that becomes “increasingly difficult and costly to manage as more bolt-on acquisitions are added.”

### Common data quality failures

The most frequently encountered data quality issues across healthcare and SaaS rollups include missing fields (acquired entities often do not track KPIs the PE firm considers essential), inconsistent formats (different date formats, currency handling, chart of accounts structures), stale data (many smaller entities report monthly or quarterly, not real-time), duplicate records (particularly acute in patient databases across healthcare rollups where the same person appears differently across systems), and schema drift (as entities upgrade or modify systems independently, previously working integrations break without warning).

**Healthcare-specific integration pain**: Different billing systems handle payment posting dates differently (date-of-deposit vs. date-of-remittance), categorize adjustments using incompatible taxonomies (one system’s “contractual adjustment” is another’s split into “contractual write-off” and “prompt-pay discount”), and apply different charge lag conventions (real-time vs. end-of-day batch vs. coding completion). Credentialing data across dozens of payers for hundreds of providers across multiple tax IDs represents a massive data management burden that directly impacts revenue — delays in credentialing mean inability to bill.

**SaaS-specific integration pain**: RSM identifies the core structural problem: “SaaS businesses often rely on a patchwork of systems — CRM/CPQ systems, billing platforms, payment gateways and accounting software. Each system may have its own data formats, definitions and update frequencies, leading to discrepancies and requiring complex reconciliation processes.” ScaleXP adds that most SaaS stacks lack “a dedicated finance intelligence layer” between operational systems and accounting — without it, finance teams must translate operational activity into financial outcomes manually, and this translation becomes “the largest source of complexity within the finance function.”

---

## Phase 3: Measurement and attribution remain unsolved problems

### The attribution impossibility

Even when PE firms achieve consolidated KPI views, connecting specific value creation initiatives to observed KPI movements remains deeply problematic. A&M’s 2024 European Value Creation Report acknowledges that “executives and investors in PE-backed companies still have to contend with the perennial challenges of limited spend visibility and muddy P&L attribution from procurement initiatives.” McKinsey found that **42% of the time, pre-merger due diligence fails to provide an adequate roadmap for capturing synergies** — if baseline expectations are flawed, attributing results to specific initiatives becomes impossible.

Gain.pro’s 2025 analysis revealed a striking pattern: **78% of deals with negative EBITDA margins achieved margin expansion (median +1,250 bps), while businesses with high margins (>30%) typically saw contraction.** This suggests much of what gets attributed to “operational value creation” may simply be regression to the mean, making genuine initiative-level attribution even harder to establish.

### Silent KPI degradation

KPIs degrade in accuracy over time through mechanisms that are rarely detected until exit diligence. FundCount warns about “weekly updates that drift into inconsistent definitions” absent strong governance. When a portfolio company upgrades its billing system, changes its chart of accounts, or modifies how it categorizes certain transactions, the data feeding into consolidated reports shifts without any alert to the operating partner. Ankura describes typical PE reporting as a “moment-in-time historical view… plagued by latency and disconnect, failing to capture the dynamic nature of business environments.”

### Reporting lag as decision-making constraint

The PE industry is transitioning from quarterly to real-time KPI access, but most portfolio companies are not equipped for this transition. When operating partners make decisions on data that is **30–90 days stale**, the effective decision-making horizon within a 5–7 year hold period shrinks dramatically. West Monroe found that the “transfer of knowledge from deal teams to operating teams, with intelligence and recommendations from the diligence report, isn’t happening as often as it should,” representing an information gap at the very start of the hold period.

### Tool landscape for VCP tracking

Current VCP tracking tools fall into three categories, each with fundamental limitations in the rollup context:

**Spreadsheets** remain the dominant tool despite obvious scale constraints. They work at 3 entities; they collapse at 10+. They cannot handle real-time data feeds, lack audit trails, and create version-control nightmares.

**BI platforms** (Power BI, Tableau, Looker) solve visualization but not harmonization. They assume clean, modeled data as input and require significant custom development — each portfolio company needs its own pipeline built, and cross-portfolio comparisons demand manual mapping of KPI definitions. Dashboards break when source systems change.

**PE portfolio monitoring software** (Chronograph, Allvue/iLevel, Cobalt, eFront) is designed for fund-level reporting (IRR, TVPI, portfolio financials), not for operational KPI tracking within multi-entity rollups. These tools collect data via forms and submissions from portfolio companies — they do not connect to source systems, do not auto-harmonize definitions, and cannot provide real-time operational visibility across 15 entities running different software.

---

## Phase 4: Human and organizational failures compound the technical ones

### Resistance patterns follow predictable arcs

Portfolio company resistance accounts for **35% of value creation initiative failures**. CVC Capital Partners observes: “Way too many VCPs fail because the people who will do the work weren’t asked to build the plan. No involvement = no buy-in.” Resistance manifests as passive non-compliance (slow data submissions, incomplete reporting), claims of business uniqueness (“our metrics can’t be standardized”), and outright slow-walking of implementation timelines.

Healthcare rollups face uniquely intense resistance. Physicians express “concerns including the loss of autonomy, the pressure to increase volume and coding intensity.” First-generation healthcare PE rollups in the mid-2000s “struggled because they underestimated the importance of physician autonomy.” Successful modern platforms have learned to “empower physicians through shared governance and the preservation of operational and clinical autonomy” — but this very autonomy makes KPI standardization harder to enforce.

### The talent gap is structural

**75–80% of CFOs turn over post-acquisition**, with 74% of US portfolio company leadership roles filled through external appointments. The departing CFOs typically understood the legacy systems; their replacements must learn them while simultaneously implementing PE-grade reporting. Many acquired companies in buy-and-build scenarios are founder-led businesses using QuickBooks with minimal finance staff — often just a bookkeeper. As one PE operating partner described: “If you’re a controller who’s been working for a privately owned family, and then a PE firm shows up that took 20 investors in their fund — it’s often a ‘What did I get myself into?’ situation.”

**Operating partner bandwidth is structurally constrained.** Senior operating partners typically oversee **3–5 companies each**, with time split across portfolio management, deal diligence, and internal governance. This means any individual company receives perhaps 10–15 hours of OP attention per month — insufficient to deeply understand the KPI infrastructure, identify definition inconsistencies, or drive system integration.

### KPI gaming exploits system opacity

S&P Global’s analysis of **700 M&A/LBO deals (2015–2024)** found that EBITDA adjustments accounted for **29% of marketed EBITDA figures**, with a direct correlation between adjustment magnitude and likelihood of underperformance. Gaming tactics include treating recurring costs as one-time (sales training reframed as a “one-time initiative”), claiming full savings from systems not yet implemented, and making pro forma adjustments for locations still under construction as though operating at capacity.

In healthcare, coding optimization that inflates revenue metrics without genuine clinical improvement is a persistent concern — the DOJ, FTC, and HHS have launched cross-government inquiries specifically targeting PE-owned practices’ coding and billing practices. In SaaS, common gaming includes changing churn calculation methodology to present the most favorable view, counting pipeline contracts as ARR, pulling forward renewals, and reclassifying professional services revenue as recurring. **Manual reporting — still used by 54% of portfolio companies — makes gaming easier** because there is no automated audit trail connecting reported numbers to source system data.

---

## Phase 5: Exit diligence exposes the accumulated debt

### The exit readiness crisis

The EY Private Equity Exit Readiness Study provides the most definitive data on this phase: **72% of PE firms identify weak data and KPI reporting as the biggest finance issue at exit**, **65% struggle to reflect value creation initiatives accurately in reported EBITDA**, and **41% lack the data granularity needed to substantiate their equity stories.**

This creates a painful paradox: the value creation that PE firms have spent years executing cannot be credibly demonstrated to buyers because the measurement infrastructure was never built properly. As EY states: “Late action typically forces a reactive data clean up during due diligence, increasing cost, management distraction and execution risk. This can lead to extended diligence timelines, buyer frustration, reduced confidence in management reporting, missed opportunities and ultimately lower valuations driven by metrics that cannot be verified.”

### How buyers evaluate KPI infrastructure maturity

Secondary PE buyers and strategic acquirers increasingly scrutinize the quality of operational reporting during diligence. The most common data room failures include inconsistent KPI definitions across entities that cannot be reconciled, Excel-maintained reporting that cannot be independently reproduced, fragmented ERP/EHR systems with “limited visibility of performance across the group,” missing historical data that prevents multi-year trend analysis, and slow response times to detailed buyer questions that signal poor data discipline.

One EY case study demonstrated the inverse: a PE-backed tech company that invested in rebuilding five years of transaction data achieved a successful exit at **10× multiple and 5× the original investment**, with churn reduction of approximately 20% driven by the data-enabled identification of at-risk customers. Another case showed a 24-month data preparation effort yielding a **15% increase in EBITDA** through identification of at-risk customers and pricing optimization. Preston Brice of Barclay Hill Partners states directly: **“Tech stack standardization is the hallmark of a good organization, and it is a value signal to acquirers.”**

In MSP rollups, buyers explicitly deduct integration costs from acquisition prices. Tim Conkle of The 20 notes: “If timely access to cohesive data is not available already at close, making it available will be among the first things the firm does after completing a purchase, and it will deduct the cost of that work in advance from the sale price.”

---

## Phase 6: No existing technology closes the full gap

### PE portfolio monitoring tools solve fund-level reporting, not rollup operations

The PE monitoring software market — Chronograph, Allvue/iLevel, Cobalt/FactSet, eFront/BlackRock — serves a different problem than the one multi-entity rollups face. These platforms excel at collecting quarterly financials from portfolio companies, calculating fund-level returns (IRR, TVPI, DPI), benchmarking against peers, and generating LP reports. **None of them connect directly to portfolio company source systems.** All assume clean data input via forms, templates, or manual submissions.

Chronograph comes closest to addressing semantic harmonization with a post-collection layer that lets firms maintain metric granularity while applying cross-portfolio labels. But it harmonizes *reported* data, not *source system* data — the definition problem persists upstream. eFront is “notorious for long, expensive implementation cycles — 6–12 months, hundreds of thousands of dollars” and is designed for fund accounting, not for tracking how 15 dental practices perform on chair utilization. Allvue’s AI assistant “Andi” enables natural-language querying of portfolio data but still requires standardized input.

### Healthcare-specific tools miss the PE use case

Veeva serves pharma/biotech, not multi-site healthcare delivery. Health Catalyst is designed for single health systems, not multi-entity rollups. Arcadia.io and Innovaccer are the closest — both integrate data from multiple healthcare sources — but both are designed for population health and value-based care analytics, not for financial/operational KPI reporting to PE sponsors. **No tool exists that specifically integrates data from multiple practice management systems and translates it into PE-relevant KPIs** (revenue per provider, same-store growth, collections rate) in a standardized way.

### Modern data stack tools require extensive custom engineering

Fivetran and Airbyte offer 300+ connectors but primarily for mainstream SaaS applications. They lack connectors for niche healthcare EMRs (eClinicalWorks, Athenahealth, NextGen), specialty practice management systems, and industry-specific platforms. dbt excels at creating semantic transformation layers but requires data engineers to manually code the “same KPI, different definition” logic for each portfolio company — it does not auto-discover semantic mappings. Snowflake and Databricks provide powerful infrastructure but are exactly that — infrastructure, not solutions.

### Consulting solves the snapshot, not the system

| Firm | Strength | Gap |
| --- | --- | --- |
| McKinsey | High-level VCP strategy, full-potential assessments | Does not build or maintain data infrastructure; delivers PowerPoints, not production systems |
| Bain | World’s largest PE advisory (80% of top PE firms); Results360® methodology | Strategic plans and frameworks, not operational data pipelines; requires ongoing engagement |
| EY-Parthenon | Transaction advisory, sector expertise | Better for pre-deal strategy than ongoing portfolio monitoring infrastructure |
| Alvarez & Marsal | Hands-on operators embedded in portcos; Rapid Results Program™ | Project-based; improvements may not persist after team departs |
| West Monroe | Technology diligence leader (500+ transactions/year); VMO for synergy tracking | Transaction-focused; custom solutions per engagement, not scalable platforms |
| Huron | Healthcare-specific (#1 in Payer IT per KLAS); developing PE-focused analytics for skilled nursing | Narrow healthcare vertical scope; not cross-vertical |
| Accordion | PE CFO-focused services; ERP/EPM implementation | Individual portco CFO functions, not cross-portfolio infrastructure |

Consulting engagements typically cost **$200K–$5M** depending on scope and firm, and the solutions they create do not persist. The KPI framework built in Month 1 degrades by Month 12 as portcos change, systems evolve, and consultants move on. This creates dependency cycles where firms return for follow-up engagements, compounding costs without building durable capability.

### The specific unmet needs

The technology gap analysis reveals four critical capabilities that no existing solution adequately addresses:

**Automated semantic harmonization**: No tool can automatically understand that “Adjusted EBITDA” in Company A (with five add-backs) differs from “Adjusted EBITDA” in Company B (with three different add-backs), or that “chair utilization” in one dental PM system maps to an equivalent but differently calculated metric in another. Today, this mapping is done manually by analysts who must understand both source systems and target definitions.

**Heterogeneous source system integration**: No PE monitoring tool connects directly to portco operational systems. The gap between “portco submits quarterly financials” (what tools handle) and “real-time operational visibility across 15 entities with different systems” (what PE firms want) is enormous.

**Automated new-acquisition onboarding**: Every new entity in a buy-and-build requires fresh integration work — typically weeks to months. No solution accelerates this process through pattern recognition or reusable semantic templates.

**Integration persistence and maintenance**: Source systems change, portcos are acquired and divested, staff turns over. Custom data pipelines require 2–5 dedicated engineers for ongoing maintenance. No solution provides self-maintaining integration that adapts when underlying systems change.

---

## Pain point severity matrix

| Rank | Pain Point | Prevalence | Severity | Solvability | Vertical Impact |
| --- | --- | --- | --- | --- | --- |
| 1 | Inconsistent KPI definitions across entities | Universal | Critical — false comparability destroys decision quality | High | Healthcare + SaaS |
| 2 | No automated source system integration | Universal | Critical — blocks real-time visibility | High | Healthcare + SaaS |
| 3 | 3–6 month delay to first consolidated report | Very high | High — dead zone for value creation | High | Healthcare + SaaS |
| 4 | Silent KPI degradation over time | Very high | High — undetected errors compound | High | Healthcare + SaaS |
| 5 | Integration complexity compounds per acquisition | Universal in rollups | Critical — nonlinear cost growth | Medium-High | Healthcare + SaaS |
| 6 | CFO turnover destroys institutional knowledge | 75–80% of portcos | High — resets reporting capability | Medium | All verticals |
| 7 | Exit diligence reveals unreproducible KPIs | 72% of PE firms | Critical — directly reduces exit valuation | High | All verticals |
| 8 | OP bandwidth insufficient for KPI governance | Very high | Medium-High — 3–5 companies per OP | Medium | All verticals |
| 9 | Manual Excel reporting at 54% of portcos | Very high | Medium-High — error-prone, non-scalable | High | All verticals |
| 10 | EHR migration disruption (healthcare) | High in healthcare | High — admissions/revenue dips during conversion | Medium | Healthcare |
| 11 | Payer mix distortion in cross-practice comparison | Universal in healthcare | Medium-High — misleading benchmarking | High | Healthcare |
| 12 | Churn methodology manipulation (SaaS) | Very high in SaaS | High — GRR can appear 35–100% for same company | High | SaaS |
| 13 | EBITDA adjustment gaming (29% of marketed figures) | Very high | High — inflates valuations, predicts underperformance | Medium | All verticals |
| 14 | Portco management resistance to standardization | 35% of VCP failures | Medium-High | Medium | All verticals |
| 15 | Consulting solutions don’t persist post-engagement | Universal | Medium — creates expensive dependency cycles | High | All verticals |
| 16 | Behavioral health outcome measurement inconsistency | High in BH | Medium-High — no standardized instruments across platforms | High | Healthcare (BH) |
| 17 | Credential data fragmentation across tax IDs | High in healthcare | Medium — delays revenue from new providers | High | Healthcare |
| 18 | CRM-billing-accounting system disconnect (SaaS) | Universal in SaaS | Medium-High — structural reconciliation burden | High | SaaS |
| 19 | Duplicate patient/customer records across entities | High | Medium — inflates counts, distorts per-unit metrics | High | Healthcare + SaaS |
| 20 | Regulatory change impact on KPI definitions (OASIS, ASC 606) | Periodic but high-impact | Medium-High — requires system-wide updates | Medium | Healthcare + SaaS |

---

## Technology gap map

| Capability | Chronograph | Allvue/iLevel | eFront | Tableau/PowerBI | Fivetran + dbt + Snowflake | Innovaccer/Arcadia | Consulting Firms |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Fund-level financial reporting | ✅ Strong | ✅ Strong | ✅ Strong | ❌ Not designed | ❌ Not designed | ❌ Not designed | ⚠️ Deliverable-based |
| Portco KPI collection | ✅ Strong | ✅ Strong | ⚠️ Quarterly | ❌ Downstream only | ❌ Not designed | ❌ Not designed | ⚠️ Project-based |
| Semantic harmonization | ⚠️ Post-collection only | ❌ Manual | ❌ None | ❌ None | ⚠️ Manual dbt models | ❌ Clinical focus | ⚠️ Point-in-time |
| Source system integration | ❌ None | ❌ None | ❌ None | ❌ None | ⚠️ Major SaaS only; no niche/healthcare | ⚠️ Healthcare EHRs only | ❌ Recommends, doesn’t build |
| Multi-entity rollup support | ⚠️ Fund view, not sub-entity | ⚠️ Limited | ❌ Fund-level | ⚠️ Custom build required | ⚠️ Extensive custom engineering | ⚠️ Single-system design | ⚠️ Per-engagement |
| New acquisition onboarding | ⚠️ Manual template setup | ⚠️ Manual | ❌ Slow | ❌ Full rebuild | ❌ New pipeline per entity | ❌ Not designed | ⚠️ New engagement |
| Ongoing maintenance/adaptation | ⚠️ User-managed | ⚠️ User-managed | ⚠️ Vendor-managed (expensive) | ❌ Breaks on schema change | ❌ Requires dedicated eng team | ⚠️ Vendor-managed | ❌ Ends with engagement |
| Real-time operational visibility | ❌ Periodic collection | ❌ Periodic collection | ❌ Quarterly | ⚠️ If pipeline exists | ⚠️ If connectors exist | ⚠️ Clinical data only | ❌ Snapshot reports |
| Healthcare-specific KPI logic | ❌ Generic | ❌ Generic | ❌ Generic | ❌ Generic | ❌ Generic | ✅ Strong (clinical) | ⚠️ Firm-dependent |
| SaaS-specific KPI logic | ❌ Generic | ❌ Generic | ❌ Generic | ❌ Generic | ❌ Generic | ❌ Not designed | ⚠️ Firm-dependent |
| Cost (Year 1) | $50K–$200K | $30K–$150K | $200K–$500K | $10K–$50K + eng cost | $100K–$300K + $300K–$1M eng | $200K–$500K | $200K–$5M |

**The critical white space**: No solution provides automated semantic harmonization of KPI definitions across heterogeneous source systems, combined with direct integration into those systems, with the ability to scale across 5–15+ entities in a buy-and-build rollup while maintaining integration persistence as systems change and new acquisitions are added.

---

## Implications for product design: MTN Data Foundry positioning

The pain point analysis reveals a precise product opportunity at the intersection of four unmet needs: semantic harmonization, heterogeneous source integration, rollup-scale maintenance, and PE-grade confidence in the resulting data. MTN Data Foundry’s positioning as a semantic data integration and AI annotation layer is directly aligned with the highest-severity, highest-prevalence gaps identified in this research.

### Semantic annotation and schema normalization for healthcare and B2B SaaS

The #1 pain point — inconsistent KPI definitions across entities — is fundamentally a semantic problem, not a data engineering problem. When five dental practices define “production per provider” using five different calculation methods, the challenge is not extracting the data from each system but *understanding what each system means* by “production” and mapping it to a canonical definition.

MTN Data Foundry’s semantic annotation layer should maintain **vertical-specific ontologies** that encode the known definition variants for each major KPI. In healthcare, this means mapping the full space of “visit” definitions (appointment-based, encounter-based, charge-based), “utilization” definitions (slot-based, time-based, wRVU-based, panel-based), “collections” definitions (gross, net, adjusted, with denominator variants), and RCM metrics (days in AR with different posting-date conventions, clean claim rates with different scrubbing definitions). In B2B SaaS, this means encoding ARR variants (recognition timing, segment inclusions, revenue stream inclusions), churn variants (logo vs. revenue, gross vs. net, measurement period, compounding method), and NRR variants (cohort-based vs. trailing, treatment of pricing changes). The system should be able to **detect which variant a source system is using** based on the data patterns, field names, and calculation logic embedded in the source, and then annotate the output with the specific definition being applied.

The **schema normalization capability** should handle the structural diversity of healthcare source systems (Epic’s data model vs. Athenahealth’s vs. eClinicalWorks’ vs. Kareo/Tebra’s) and SaaS source systems (Salesforce objects vs. HubSpot properties vs. Zoho modules; Stripe event models vs. Zuora subscription objects vs. Chargebee data structures). The normalization should operate at the semantic level — understanding that Epic’s “Encounter” table, Athenahealth’s “Appointment” record, and eClinicalWorks’ “Visit” entry may represent equivalent clinical events but with different field structures, different status codes, and different relationships to billing records.

### LLM ensemble and embedding-based KPI definition harmonization

The KPI harmonization engine should use an **LLM ensemble approach** that combines multiple reasoning strategies: pattern-matching against known definition templates (the 7 dimensions of ARR variation, the 4 major “visit” definitions), semantic similarity via embeddings to identify equivalent fields across different schemas, and domain-specific reasoning to flag when two apparently similar metrics are actually measuring different things (e.g., “net collections” calculated against charges vs. allowed amounts).

The system should generate an **explicit “KPI definition card”** for each metric from each source system, specifying the numerator, denominator, inclusion/exclusion rules, timing conventions, and any adjustments applied. These cards become the basis for harmonization — when two systems’ “utilization” metrics are mapped, the card shows exactly what each system means, where they agree, where they differ, and what transformation is required to make them comparable. This directly addresses the MGMA finding that even single organizations struggled for years to define NPR/wRVU consistently.

For PE operating partners, the system should produce **“definition divergence reports”** that highlight where portfolio companies’ metrics appear comparable but are calculated differently, quantify the impact of the divergence (e.g., “Provider utilization at Practice A would be 78% instead of 85% if calculated using Practice B’s methodology”), and recommend a harmonized definition with transparent documentation of the choices made. This converts what is currently a months-long consulting engagement into a continuous, automated capability.

### Confidence-scored, human-in-the-loop review for ambiguous mappings

Not all semantic mappings are high-confidence. When mapping a behavioral health platform’s “session” metric (which may combine individual therapy, group therapy, and medication management encounters with different billing rules) to a canonical definition, the system should assign a **confidence score** reflecting the quality of the mapping. High-confidence mappings (e.g., a standard Athenahealth “Charge” record mapping to a canonical “billable encounter”) proceed automatically. Low-confidence mappings (e.g., a custom field in an eClinicalWorks instance that appears to track utilization but uses non-standard logic) are flagged for human review.

The human-in-the-loop workflow should be designed for the **actual personas who will use it**: PE operating partners (who need high-level summary views of what is and isn’t harmonized, with “approve all” capability for straightforward mappings), portfolio company CFOs (who need to validate that their specific business logic is correctly captured), and data analysts (who need technical detail on field-level mappings and transformation logic). Given that operating partners oversee 3–5 companies with limited bandwidth, the review interface must minimize cognitive load — presenting ambiguous mappings as clear choices (“Is ‘utilization’ at this practice calculated as booked/available or seen/available?”) rather than technical schema diagrams.

The confidence scoring should also serve as an **ongoing data quality monitor**. When source system changes cause mapping confidence to drop (e.g., a billing system upgrade changes field names or calculation logic), the system should proactively alert the relevant stakeholders rather than silently degrading KPI accuracy — directly addressing the “silent degradation” problem that 72% of PE firms encounter at exit.

### Platform targeting: PE operating partners and CFOs at mid-market healthcare and B2B SaaS rollups

The ideal initial target customer profile, based on this research, is a **PE operating partner or platform CFO managing a 5–15 entity healthcare or B2B SaaS rollup** in the middle market ($50M–$500M enterprise value). This persona faces the most acute version of every pain point identified: enough entities to make manual consolidation unworkable, enough system heterogeneity to make standardization expensive, enough M&A velocity to make maintenance continuous, and enough exit pressure to make data quality existential.

The product should position against **three specific buying triggers**: the “first board meeting after the third acquisition” moment (when manually consolidated KPIs visibly break down), the “operating partner realizes definitions don’t match” moment (when cross-entity benchmarking produces nonsensical comparisons), and the “12 months pre-exit” moment (when data room preparation reveals that KPIs cannot be independently reproduced). Each trigger corresponds to a different entry point and value proposition, but all lead to the same core capability: trustworthy, harmonized, source-system-connected KPI infrastructure that scales with the rollup and persists through the hold period.

The **pricing model** should reflect PE economics: platform-level licensing with per-entity add-on pricing that aligns with the buy-and-build model (each new acquisition adds a predictable increment), with implementation timelines measured in weeks rather than months. If the current median time to first consolidated report is 3–6 months, delivering a harmonized KPI view in **4–6 weeks per new acquisition** — with confidence scores indicating where human review is still needed — would represent a step-change that directly accelerates value creation.

### Five capabilities mapped to highest-severity gaps

Based on the severity matrix, MTN Data Foundry’s roadmap should prioritize:

1. **Rapid acquisition onboarding** (addresses #2, #3, #5): A templated integration workflow for common healthcare and SaaS source systems that reduces new-entity onboarding from months to weeks, with pre-built semantic models for the most common EHR, PM, CRM, and billing platforms.
2. **Continuous definition monitoring** (addresses #1, #4, #7): Always-on comparison of how each entity’s source system defines each KPI, with drift detection that catches silent changes before they corrupt reporting — converting the 72% exit-readiness failure rate into a continuous governance capability.
3. **Payer-mix and methodology normalization** (addresses #11, #12): Healthcare-specific payer-mix adjustment that enables apples-to-apples comparison across practices with different insurance profiles; SaaS-specific churn/retention methodology normalization that exposes the impact of calculation choices on reported metrics.
4. **Audit-ready KPI lineage** (addresses #7, #9, #13): Complete data lineage from source system field to reported KPI, enabling independent reproduction of any metric during exit diligence — directly addressing the data room failure modes that destroy deal certainty and valuation.
5. **Operating partner dashboard with bandwidth-appropriate design** (addresses #8): A portfolio-level view that surfaces the 3–5 most important signals per company per week, with drill-down available but not required — designed for the reality that OPs have 10–15 hours per company per month.

---

## Conclusion: The infrastructure layer is the missing piece

The PE industry has reached a structural inflection point. With **$3.8 trillion in unsold inventory**, holding periods at record highs, and entry multiples demanding unprecedented operational improvement, the ability to measure and drive value creation is no longer optional — it is the primary determinant of returns. Yet the infrastructure required to do this reliably across multi-entity rollups does not exist in any commercially available product.

The pain points documented here are not edge cases. They are universal across healthcare and B2B SaaS rollups, they compound with every acquisition, and they directly destroy value at both ends of the hold period — through delayed value creation during the hold and reduced exit certainty at sale. The **$2–5M annual waste** from poor portfolio visibility, the **3–6 month dead zones** before first consolidated reporting, the **29% EBITDA adjustment inflation**, and the **72% of PE firms citing weak KPI reporting as their top exit concern** all point to the same gap: no one has built the semantic integration layer that sits between heterogeneous source systems and PE-grade operational reporting.

The firms that build this capability — whether through internal investment, third-party platforms, or both — will compound a durable advantage across every deal in their portfolio. The firms that don’t will continue to make decisions on data they can’t trust, present exit stories they can’t substantiate, and leave value on the table at a time when the industry can least afford it.
